Lyrical Asset Management LP Has $123.40 Million Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Key Points

• Lyrical Asset Management LP reduced its holdings in Henry Schein, Inc. by 1.6%, now owning approximately $123.40 million in stock.
• Henry Schein's stock has seen a 2.2% increase recently, trading at around $68.99, with a market cap of $8.37 billion.
• The company's latest earnings report showed EPS of $1.10, missing estimates, but revenue increased by 3.3% year-over-year to $3.24 billion.

Lyrical Asset Management LP decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 1.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,801,661 shares of the company's stock after selling 28,615 shares during the quarter. Henry Schein comprises approximately 1.9% of Lyrical Asset Management LP's holdings, making the stock its 25th biggest holding. Lyrical Asset Management LP owned approximately 1.48% of Henry Schein worth $123,396,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. bought a new stake in shares of Henry Schein during the 1st quarter valued at about $34,000. Whittier Trust Co. grew its position in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the last quarter. UMB Bank n.a. grew its position in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the last quarter. Finally, Allworth Financial LP grew its position in shares of Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after buying an additional 232 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Down 0.1%

HSIC stock traded down $0.07 during midday trading on Friday, reaching $67.84. The company had a trading volume of 1,675,382 shares, compared to its average volume of 2,075,710. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $8.23 billion, a P/E ratio of 21.88, a PEG ratio of 2.24 and a beta of 0.81. The company has a 50 day moving average of $70.81 and a two-hundred day moving average of $70.78.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The business had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the prior year, the business posted $1.23 EPS. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HSIC shares. Wells Fargo & Company lowered their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. UBS Group lowered their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, August 6th. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research report on Thursday, August 7th. Evercore ISI reduced their price target on shares of Henry Schein from $78.00 to $70.00 and set an "in-line" rating for the company in a research note on Wednesday, August 6th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a report on Monday, July 14th. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Henry Schein currently has an average rating of "Hold" and an average target price of $75.58.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.